ArticleMolecular biology reports2026
Multidrug-resistant Escherichia coli ST940 carrying bla
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA bacterial genome continuously evolves, modifying its genetic makeup to wage a war against the antibiotics. Carbapenem-resistant Enterobacterales have challenged the efficacy of last resort antibiotics. It’s crucial to complement the phenotypic understanding of bacterial isolates with genotypic analysis, for an-in depth understanding of antibiotic resistance genes (ARGs) and characteristic features aiding the transmission of ARGs. METHODS AND
resultsIn this study, we screened community wastewater of Aligarh, a major city in northern India for the prevalence of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae. From antibiotic susceptibility test, we identified six E. coli and two K. pneumoniae isolates exhibiting resistance against both imipenem and meropenem. With PCR, we found one E. coli isolate out of this (AK-633) carried the high-risk carbapenemase gene blaNDM−7. The whole-genome sequencing of AK-633 revealed the gene blaNDM−7 was carried by a mosaic plasmid, plasmid_1550 harboring incompatibility types IncFII/IncFIA/IncFIB. Further, the density and diversity of transposable elements and insertion sequences indicate an active history of recombination and horizontal gene exchange, supporting the role of plasmid_1550 as a potent vehicle for the accumulation and dissemination of ARGs within bacterial populations.
conclusionThe detection of blaNDM−7, harobored by a mosaic plasmid in an E. coli ST940 strain from wastewater in our study adds to growing evidence that environmental reservoirs may significantly contribute to the emergence, maintenance, and global spread of high-risk clones and their associated resistance plasmids.
Indexed as
Identifiers
41989677What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.